APEN Stock - Apollo Endosurgery, Inc.
Unlock GoAI Insights for APEN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $76.86M | $62.99M | $42.05M | $50.71M | $60.85M |
| Gross Profit | $42.43M | $34.96M | $22.24M | $25.68M | $33.19M |
| Gross Margin | 55.2% | 55.5% | 52.9% | 50.6% | 54.5% |
| Operating Income | $-27,822,000 | $-19,199,000 | $-15,794,000 | $-29,122,000 | $-40,093,000 |
| Net Income | $-39,839,000 | $-24,682,000 | $-22,611,000 | $-27,432,000 | $-45,787,000 |
| Net Margin | -51.8% | -39.2% | -53.8% | -54.1% | -75.2% |
| EPS | $-0.98 | $-0.82 | $-0.99 | $-1.27 | $-2.31 |
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Visit WebsiteEarnings History & Surprises
APENEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2023 | Mar 30, 2023 | $-0.21 | $0.23 | +209.5% | ✓ BEAT |
Q4 2022 | Nov 1, 2022 | $-0.23 | $-0.28 | -21.7% | ✗ MISS |
Q3 2022 | Aug 2, 2022 | $-0.22 | $-0.26 | -18.2% | ✗ MISS |
Q2 2022 | May 3, 2022 | $-0.20 | $-0.21 | -5.0% | ✗ MISS |
Q1 2022 | Feb 22, 2022 | $-0.19 | $-0.27 | -42.1% | ✗ MISS |
Q4 2021 | Nov 1, 2021 | $-0.28 | $-0.23 | +17.9% | ✓ BEAT |
Q3 2021 | Aug 3, 2021 | $-0.20 | $-0.11 | +45.0% | ✓ BEAT |
Q2 2021 | May 4, 2021 | $-0.22 | $-0.17 | +22.7% | ✓ BEAT |
Q1 2021 | Feb 25, 2021 | $-0.25 | $-0.14 | +44.0% | ✓ BEAT |
Q4 2020 | Nov 5, 2020 | $-0.21 | $-0.11 | +47.6% | ✓ BEAT |
Q3 2020 | Aug 4, 2020 | $-0.33 | $-0.30 | +9.1% | ✓ BEAT |
Q2 2020 | May 4, 2020 | $-0.49 | $-0.49 | 0.0% | = MET |
Q1 2020 | Mar 26, 2020 | $-0.38 | $-0.34 | +10.5% | ✓ BEAT |
Q4 2019 | Oct 30, 2019 | $-0.42 | $-0.40 | +4.8% | ✓ BEAT |
Q3 2019 | Jul 23, 2019 | $-0.38 | $-0.40 | -5.3% | ✗ MISS |
Q2 2019 | May 2, 2019 | $-0.36 | $-0.13 | +63.9% | ✓ BEAT |
Q1 2019 | Mar 18, 2019 | $-0.37 | $-0.48 | -29.7% | ✗ MISS |
Q4 2018 | Nov 8, 2018 | $-0.35 | $-0.45 | -28.6% | ✗ MISS |
Q3 2018 | Aug 8, 2018 | $-0.44 | $-0.53 | -20.5% | ✗ MISS |
Q2 2018 | May 3, 2018 | $-0.40 | $-0.47 | -17.5% | ✗ MISS |
Latest News
Frequently Asked Questions about APEN
What is APEN's current stock price?
What is the analyst price target for APEN?
What sector is Apollo Endosurgery, Inc. in?
What is APEN's market cap?
Does APEN pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to APEN for comparison